Ravi Kane has joined the School of Chemical and Biomolecular Engineering as a professor and holder of the Garry Betty/V Foundation Chair and GRA Eminent Scholar in Cancer Nanotechnology. Kane will hold also program faculty status in the Wallace H. Coulter Department of Biomedical Engineering at Georgia Tech and Emory University.
Previously, Kane served on the faculty of Rensselaer Polytechnic Institute, where he was head of the Department of Chemical and Biological Engineering and held the P.K. Lashmet Professorship.
“Ravi is a wonderfully creative and effective researcher, and we are thrilled to have him join us at Georgia Tech,” said Professor and ChBE School Chair David Sholl.
Holding master’s and doctoral degrees from Massachusetts Institute of Technology (MIT), Kane focuses his research on the interface of biotechnology and nanotechnology.
His research group is designing nanoscale polyvalent therapeutics and working on the molecular engineering of biosurfaces and nanostructures. The Kane group is also interested in using protein engineering, nanotechnology, and other tools to combat cancer, Alzheimer’s, Parkinson’s disease, influenza, and antibiotic-resistant pathogens.
Having contributed to more than 125 scientific publications, Kane has received numerous honors throughout his career. In 2004, MIT Technology Review named him one of the top 100 young innovators in the world.
Nanobiotechnology expert Ravi Kane, the P.K. Lashmet Professor at Rensselaer Polytechnic Institute, has been named head of the university’s Howard P. Isermann Department of Chemical and Biological Engineering (CBE).
“Dr. Kane is an internationally respected scholar known for interdisciplinary research, an award- winning educator, and an exceptional mentor. We are delighted to have him lead CBE as the department head,” said Shekhar Garde, dean of the School of Engineering at Rensselaer. “Ravi’s vision, leadership, and intellect will be vital for the continuing transformation of CBE, as the department grows its faculty, students, and global reputation for excellence in education and research.”
CBE is home to more than 350 undergraduate and nearly 100 doctoral students and postdoctoral fellows. Faculty and students work at the interface of fundamental sciences and engineering to solve some of the most critical problems facing humanity, including energy, sustainability, human health, and water security. They tackle topics ranging from advancing artificial pancreas technology for people with Type I diabetes, to understanding the behavior of bacteria in the microgravity of space, to using protein engineering, nanotechnology, and other tools to fight cancer, Alzheimer’s, and Parkinson’s disease.
Kane received his bachelor’s degree from Stanford University, and his master’s and doctoral degrees from Massachusetts Institute of Technology, all in chemical engineering. He joined the Rensselaer faculty in 2001, following a postdoctoral fellowship at Harvard University. He was promoted to associate professor in 2006, full professor in 2007, and named the P.K. Lashmet Professor in 2008.